CD4 and myeloid sarcoma: Similarly, CD4+IL-10+ cells were also increased and positively correlated with the Th17 subset (Fig 5C and 5D, r = 0.69; p<0.01 and S4C Fig) within the MS cohort, which denotes robust compensatory mechanisms that are insufficient at controlling the pathogenic response in these patients.